Blood News and Research

RSS

MRI helps predict recovery after spinal cord injury

Using magnetic resonance imaging (MRI), radiologists can better predict the likelihood of full or partial recovery of patients with acute spinal cord injuries (SCI), according to a study published in the June issue of the journal Radiology.

30 May 2007

Northwestern University researchers find drug reactions six years earlier than the FDA and drug companies

Northwestern University's Charles Bennett, M.D., is a super sleuth of potentially deadly prescription drug reactions.

30 May 2007

Rapid syphilis testing prevents congenital disease and stillbirths

Congenital syphilis is a major preventable public health problem in many developing countries, frequently causing stillbirths or neonatal death and disabling children who survive.

30 May 2007

3-D plasma coating technique keeps veins and arteries open

Scientists at the University of Ulster are working on a new method of coating stents – the medical devices used to keep veins and arteries open – to prevent them blocking up.

30 May 2007

New class of compounds shows promise for cancer treatment

A new class of compounds developed by two University of Kentucky researchers shows promise as a nontoxic treatment of some cancers previously treated with toxic chemotherapy, the researchers report.

30 May 2007

Natural chemical with memory-enhancing effects

A natural compound found in blueberries, tea, grapes, and cocoa enhances memory in mice, according to newly published research.

30 May 2007

Vitamin D and calcium lower risk of premenopausal breast cancer

Women who consume higher amounts of calcium and vitamin D may have a lower risk of developing premenopausal breast cancer, according to a report in the May 28 issue of Archives of Internal Medicine.

30 May 2007

Human antibodies protect mice from H5N1 avian influenza

An international team of scientists, including researchers from the National Institute of Allergy and Infectious Diseases (NIAID), report using antibodies derived from immune cells from recent human survivors of H5N1 avian influenza to successfully treat H5N1-infected mice as well as protect them from an otherwise lethal dose of the virus.

30 May 2007

HIV and malaria combine to adversely affect pregnant women and their infants

University of Toronto researchers have uncovered the basis by which pregnant women protect themselves against malaria and have also discovered how the HIV virus works to counteract this defence.

30 May 2007

Ground breaking research to give lasting relief from dye eyes

University of Western Sydney researcher, Associate Professor Tom Millar has approached the problem of dry eyes from a new perspective.

30 May 2007

Magnetic resonance-guided, focused ultrasound surgery relieves fibroid symptoms in women

A noninvasive ultrasound procedure effectively shrinks uterine fibroids and significantly relieves fibroid-related symptoms in women, according to the results of a multicenter clinical trial reported in the June issue of the journal Radiology.

30 May 2007

Regular exercise increases "good" cholesterol

Regular exercise appears to modestly increase levels of high-density lipoprotein, or "good," cholesterol, according to a meta-analysis study in the May 28 issue of Archives of Internal Medicine , one of the JAMA/Archives journals.

30 May 2007

Inflammation linked to Alzheimer's disease

People whose blood shows signs of inflammation are more likely to later develop Alzheimer's disease than people with no signs of inflammation, according to a study published in the May 29, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.

30 May 2007

H5N1 influenza virus survivors' antibodies effective at neutralising H5N1 strain

Adults who have recovered from the potentially deadly H5N1 strain of avian influenza may hold the key to future treatments for the virus, according to an international team of researchers.

30 May 2007

Blood of bird flu survivors promises new treatment for the deadly virus

Scientists are optimistic that blood donated by four survivors of bird flu will offer some clues as to why some people appear to have protection against the deadly H5N1 virus.

29 May 2007

Natalizumab returns to market

Just months after receiving FDA approval, natalizumab, a medication for the treatment of multiple sclerosis (MS) and other inflammatory disorders, was voluntarily withdrawn by its manufacturers after three patients developed a brain infection known as Progressive Multifocal Leukoencephalopathy (PML).

28 May 2007